Stock UniverseDerived research view · source repositories remain read-only

Pharming Group N.V. (PHAR)

Therapeutics / Biopharma · Healthcare / Biotechnology
Score Band
Qualified
Selection Score
36.96
Global Rank
912
Market Cap
1.13B
Latest Close
12.54
RS Composite
-25.73% · G#2879

Price Movement

3Y daily adjusted close
Loading price data...
Adjusted close SMA60D
1M
-23.53%
3M
-18.77%
6M
-20.68%
1Y
3.11%
3Y
4.51%
5Y
3.22%
10Y
-24.90%

Volume

Loading volume data...
Volume Volume MA20D

Latest volume: 10.65K · 30-day average: 14.12K · Max drawdown over stored range: -60.45%

Research Snapshot

Relative Strength vs SPX

RS Composite-25.73%
20D RS3.87%
60D RS-30.00%
120D RS-36.26%
Global RS Rank2879 · 14.19% percentile
Qualified+ RS Rank1113 · 11.53% percentile
Group ScopeQualified+
Primary RS Rank338 · 26.20% percentile
Snapshot Date2026-06-05

RS uses adjusted close where available. Global RS Rank is recalculated from the current non-low pool. Group RS Rank is recalculated inside the company’s own actionable band group.

Research Links

StockAnalysis
Yahoo Finance
Perplexity Finance
Finviz
Seeking Alpha
WhaleWisdom
FinanceCharts
SEC EDGAR Search
SEC Company Search

Official company website and investor-relations URLs are not inferred unless a reliable dynamic source is added.

Classification

Primary Rank165 / 701
Primary Percentile76.60
Score Notesmarket-cap support, industry-tailwind

Gemini Deep Research

Loading Gemini reports...

Manual Estimates

Loading manual estimates...

Forward Valuation

Loading forward valuation...

SEC TTM Fundamentals

No processed TTM rows for PHAR.

TTM Valuation

No SEC TTM valuation available.

Financial Statement Metrics

MetricFY 2020FY 2021FY 2022FY 2023FY 2024FY 2025
Revenue212.174198.871205.622245.316297.2376.134
Revenue Growth (YoY)12.031%-6.27%3.395%19.304%21.15%26.559%
Gross Profit188.635177.729188.06220.104261.801
Operating Income76.2562410.367-21.75-3.594
Free Cash Flow78.96927.10321.082-18.739-2.58553.959
Free Cash Flow Per Share0.1160.0390.03-0.029-0.0040.722472
EPS (Diluted) GAAP0.0549990.0229990.019-0.016054-0.017999
EPS Growth-9.838%-58.183%-17.388%13000%13000%
EPS Non-GAAP
Gross Margin88.906%89.369%91.459%89.723%88.089%87.9032%
Operating Margin35.94%12.068%5.042%-8.866%-1.209%-79.3691%
Profit Margin17.79%8.043%6.65%-4.3%-3.984%0.6748%
Free Cash Flow Margin37.219%13.628%10.253%-7.639%-0.87%14.3457%
Shares Outstanding (Diluted)682.7373701.1515707.1413657.0205671.347371.275
Shares Change (YoY)1.369%2.697%0.854%-7.088%2.181%-9.251%

SEC Quarterly Fundamentals

No processed quarterly rows for PHAR.